DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,145 | -1.7% | 1,935 | -4.9% | 0.06% | 0.0% |
| Q2 2023 | $488,461 | +5.7% | 2,035 | +11.0% | 0.06% | -1.6% |
| Q1 2023 | $462,045 | -5.4% | 1,833 | -0.4% | 0.06% | -10.0% |
| Q4 2022 | $488,424 | +2.2% | 1,840 | -0.5% | 0.07% | -4.1% |
| Q3 2022 | $478,000 | -2.0% | 1,849 | -4.0% | 0.07% | +19.7% |
| Q2 2022 | $488,000 | -14.8% | 1,926 | -1.4% | 0.06% | -7.6% |
| Q1 2022 | $573,000 | -14.3% | 1,953 | -3.9% | 0.07% | -9.6% |
| Q4 2021 | $669,000 | +3.4% | 2,032 | -4.3% | 0.07% | -6.4% |
| Q3 2021 | $647,000 | +24.7% | 2,124 | +9.8% | 0.08% | +23.8% |
| Q2 2021 | $519,000 | +11.4% | 1,935 | -6.5% | 0.06% | +1.6% |
| Q1 2021 | $466,000 | +1.3% | 2,070 | -0.0% | 0.06% | -4.6% |
| Q4 2020 | $460,000 | -10.3% | 2,071 | -13.1% | 0.06% | -20.7% |
| Q3 2020 | $513,000 | +13.0% | 2,383 | -7.2% | 0.08% | +5.1% |
| Q2 2020 | $454,000 | +22.0% | 2,569 | -4.4% | 0.08% | -2.5% |
| Q1 2020 | $372,000 | -17.9% | 2,688 | -9.0% | 0.08% | +5.3% |
| Q4 2019 | $453,000 | +9.7% | 2,953 | +3.4% | 0.08% | -1.3% |
| Q3 2019 | $413,000 | +2.0% | 2,857 | +0.8% | 0.08% | -6.1% |
| Q2 2019 | $405,000 | +10.4% | 2,834 | +2.1% | 0.08% | +30.2% |
| Q1 2019 | $367,000 | +19.9% | 2,777 | -6.3% | 0.06% | 0.0% |
| Q4 2018 | $306,000 | -9.5% | 2,963 | -4.8% | 0.06% | +10.5% |
| Q3 2018 | $338,000 | +22.9% | 3,112 | +11.9% | 0.06% | +14.0% |
| Q2 2018 | $275,000 | +13.2% | 2,782 | +12.1% | 0.05% | +11.1% |
| Q1 2018 | $243,000 | +37.3% | 2,482 | +30.1% | 0.04% | +40.6% |
| Q4 2017 | $177,000 | – | 1,908 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |